BRIEF published on 07/08/2024 at 08:05, 4 months 13 days ago Noratis AG Schedules Bondholders' Meeting to Extend Corporate Bond Term Extension Real Estate Market Corporate Bond Noratis AG
PRESS RELEASE published on 07/08/2024 at 08:00, 4 months 13 days ago EQS-Adhoc: Noratis AG: Noratis AG convenes bondholders' meeting for an extension of the corporate bond 2020/2025 until 31 December 2028 Noratis AG announces bondholders' meeting to extend corporate bond 2020/2025 until 31 Dec 2028 due to real estate market challenges Extension Real Estate Market Corporate Bond Bondholders' Meeting Noratis AG
BRIEF published on 05/27/2024 at 09:35, 5 months 25 days ago Noratis AG Publishes 2023 Business Figures Real Estate EBIT 2023 Business Figures Noratis AG
PRESS RELEASE published on 05/27/2024 at 09:30, 5 months 25 days ago Noratis AG publishes business figures for 2023 Noratis AG reports 2023 business figures with EBIT at EUR 3.5 million, rental income up 10.7%, and group result at EUR -11.0 million. The challenging market environment leads to cost-cutting measures for 2024 2023 Business Figures EBIT Rental Income Noratis AG
PRESS RELEASE published on 09/29/2023 at 11:59, 1 year 1 month ago Noratis AG: 2023 first-half earnings in line with expectations
PRESS RELEASE published on 07/19/2023 at 16:09, 1 year 4 months ago Noratis AG: Noratis AG annual general meeting passes all agenda items with a large majority
PRESS RELEASE published on 06/28/2023 at 10:00, 1 year 4 months ago Noratis AG: Noratis AG with change in the Supervisory Board
PRESS RELEASE published on 05/31/2023 at 07:30, 1 year 5 months ago Noratis AG: Noratis AG confirms preliminary figures 2022 and holds webcast on results
PRESS RELEASE published on 04/18/2023 at 08:30, 1 year 7 months ago Noratis AG: At EUR 8.3 million, preliminary consolidated net income for 2022 only slightly below prior year (EUR 9.5 million) despite difficult market conditions
PRESS RELEASE published on 02/09/2023 at 08:30, 1 year 9 months ago Noratis AG: Noratis sells property portfolio in Celle
Published on 11/21/2024 at 13:00, 35 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 35 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 35 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 35 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 35 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 59 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 20 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 37 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 15 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 50 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 50 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
